184 related articles for article (PubMed ID: 10517430)
21. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.
Huang H; Coleman S; Bridge JA; Yonkers K; Katon W
Gen Hosp Psychiatry; 2014; 36(1):13-8. PubMed ID: 24094568
[TBL] [Abstract][Full Text] [Related]
22. Association between antidepressant drug use during pregnancy and child healthcare utilisation.
Ververs TF; van Wensen K; Freund MW; van der Heide M; Visser GH; Schobben AF; de Jong-van den Berg LT; Egberts AC
BJOG; 2009 Nov; 116(12):1568-77. PubMed ID: 19681852
[TBL] [Abstract][Full Text] [Related]
23. Weight gain in breastfed infants of mothers taking antidepressant medications.
Hendrick V; Smith LM; Hwang S; Altshuler LL; Haynes D
J Clin Psychiatry; 2003 Apr; 64(4):410-2. PubMed ID: 12716242
[TBL] [Abstract][Full Text] [Related]
24. Depression during pregnancy: diagnosis and treatment options.
Nonacs R; Cohen LS
J Clin Psychiatry; 2002; 63 Suppl 7():24-30. PubMed ID: 11995775
[TBL] [Abstract][Full Text] [Related]
25. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.
Ross LE; Grigoriadis S; Mamisashvili L; Vonderporten EH; Roerecke M; Rehm J; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A
JAMA Psychiatry; 2013 Apr; 70(4):436-43. PubMed ID: 23446732
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant use during pregnancy: the benefit-risk ratio.
Koren G; Nordeng H
Am J Obstet Gynecol; 2012 Sep; 207(3):157-63. PubMed ID: 22425404
[TBL] [Abstract][Full Text] [Related]
27. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis.
McDonagh MS; Matthews A; Phillipi C; Romm J; Peterson K; Thakurta S; Guise JM
Obstet Gynecol; 2014 Sep; 124(3):526-534. PubMed ID: 25004304
[TBL] [Abstract][Full Text] [Related]
28. Pharmacotherapy of depression in pregnancy.
Patkar AA; Bilal L; Masand PS
Ann Clin Psychiatry; 2004; 16(2):87-100. PubMed ID: 15328902
[TBL] [Abstract][Full Text] [Related]
29. Controversies about the use of antidepressants in pregnancy.
Robinson GE
J Nerv Ment Dis; 2015 Mar; 203(3):159-63. PubMed ID: 25714252
[TBL] [Abstract][Full Text] [Related]
30. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.
Andrade SE; McPhillips H; Loren D; Raebel MA; Lane K; Livingston J; Boudreau DM; Smith DH; Davis RL; Willy ME; Platt R
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):246-52. PubMed ID: 19148882
[TBL] [Abstract][Full Text] [Related]
31. Birth outcomes following prenatal exposure to antidepressants.
Pearson KH; Nonacs RM; Viguera AC; Heller VL; Petrillo LF; Brandes M; Hennen J; Cohen LS
J Clin Psychiatry; 2007 Aug; 68(8):1284-9. PubMed ID: 17854255
[TBL] [Abstract][Full Text] [Related]
32. Taking antidepressants during late pregnancy. How should we advise women?
Kalra S; Einarson A; Koren G;
Can Fam Physician; 2005 Aug; 51(8):1077-8. PubMed ID: 16121827
[TBL] [Abstract][Full Text] [Related]
33. Offspring Outcomes in Studies of Antidepressant-Treated Pregnancies Depend on the Choice of Control Group.
Andrade C
J Clin Psychiatry; 2017 Mar; 78(3):e294-e297. PubMed ID: 28394511
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring's outcomes.
Prady SL; Hanlon I; Fraser LK; Mikocka-Walus A
Arch Womens Ment Health; 2018 Apr; 21(2):127-140. PubMed ID: 29027013
[TBL] [Abstract][Full Text] [Related]
35. Maternal Antidepressant Use During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in Children: A Systematic Review of the Current Literature.
Uguz F
J Clin Psychopharmacol; 2018 Jun; 38(3):254-259. PubMed ID: 29596147
[TBL] [Abstract][Full Text] [Related]
36. Neonate characteristics after maternal use of antidepressants in late pregnancy.
Källén B
Arch Pediatr Adolesc Med; 2004 Apr; 158(4):312-6. PubMed ID: 15066868
[TBL] [Abstract][Full Text] [Related]
37. Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure.
Barbui C; Ostuzzi G
Evid Based Ment Health; 2014 Aug; 17(3):69-71. PubMed ID: 24938274
[No Abstract] [Full Text] [Related]
38. Neonatal adaptation following intrauterine antidepressant exposure: assessment, drug assay levels, and infant development outcomes.
Galbally M; Spigset O; Johnson AR; Kohan R; Lappas M; Lewis AJ
Pediatr Res; 2017 Nov; 82(5):806-813. PubMed ID: 28665925
[TBL] [Abstract][Full Text] [Related]
39. A common clinical conundrum: Antidepressant treatment of depression in pregnant women.
Mesches GA; Wisner KL; Betcher HK
Semin Perinatol; 2020 Apr; 44(3):151229. PubMed ID: 32085857
[TBL] [Abstract][Full Text] [Related]
40. Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.
Man KKC; Chan EW; Ip P; Coghill D; Simonoff E; Chan PKL; Lau WCY; Schuemie MJ; Sturkenboom MCJM; Wong ICK
BMJ; 2017 May; 357():j2350. PubMed ID: 28566274
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]